Here's an excerpt from PharmD candidate Chris Stang's article. Sign-up to join our trading team and access our Money Moves!
"Ionis Pharmaceuticals (IONS) has been pushing all-time-highs, which was sparked by a very positive full year 2018 earning report and business update at the end of February. Last week, shares sold off nearly 14%, on what I believe to be a combination of the several factors . . .
